Venture Capital

Turn Therapeutics: $25 Million Financing Secured By Dermatology Biotechnology Company

By Amit Chowdhry ● Mar 31, 2026

Turn Therapeutics, a clinical-stage dermatology biotechnology company, announced it has secured up to $25 million in financing through a growth capital loan facility with Avenue Capital Group. The agreement includes an initial $7 million tranche funded at closing, with an additional $18 million available upon the achievement of clinical and corporate milestones.

Nuvilab: AI Nutrition Analytics Startup Raises Series A Bridge Funding To Expand In North America

By Amit Chowdhry ● Mar 31, 2026

NAVER’s venture arm NAVER D2SF has made a follow-on investment in Nuvilab, participating in the company’s Series A bridge round as it accelerates expansion into the North American healthcare market.

Niyam Group: J.C. Flowers Invests To Launch Indian Reinsurance Platform And Lloyd’s Syndicate

By Amit Chowdhry ● Mar 31, 2026

J.C. Flowers & Co. has announced an agreement to acquire a controlling stake in Niyam Group while also serving as lead investor in Niyam Syndicate 2047, a newly established syndicate at Lloyd’s. The move marks the creation of a new reinsurance platform designed to connect global capital with opportunities in India and other high-growth markets.

Boston Green Company: Fort Point Capital Investment To Expand Environmental Services Platform

By Amit Chowdhry ● Mar 31, 2026

Boston Green Company, an environmental services provider based in Freetown, Massachusetts, has received an investment from Fort Point Capital, marking a recapitalization aimed at accelerating the company’s growth and expansion.

Congruence Therapeutics: $39.5 Million Secured To Advance Small Molecule Correctors Into Clinical Development

By Amit Chowdhry ● Mar 31, 2026

Congruence Therapeutics has announced the closing of a $39.5 million financing to support the advancement of its pipeline of small molecule correctors targeting diseases caused by protein misfolding. The financing round was co-led by Dimension and OrbiMed, with participation from Amplitude Ventures, FSTQ, Lumira Ventures, Investissement Québec, BDC Capital, Driehaus Capital Management, and Silver Arc.

Laigo Bio: €17 Million Raised For Biotech Developing SureTACs Precision Protein Degradation Platform

By Amit Chowdhry ● Mar 31, 2026

Laigo Bio, a Netherlands-based biotech company developing targeted protein degradation therapies, has completed the final close of its oversubscribed seed financing round, bringing the total raised to €17 million.

Posh: $37 Million Raised For Digital Ticketing And Event Management Platform Expansion

By Amit Chowdhry ● Mar 31, 2026

Posh, a NYC-based digital ticketing and event management platform, has raised $37 million in a Series B funding round led by FirstMark, with participation from Causeway Ventures, Goodwater Capital, Companyon Ventures, and Epic Ventures.

Cleavr: $1 Million Raised For AI Accounts Receivable Automation Platform

By Amit Chowdhry ● Mar 31, 2026

Cleavr, a Paris-based developer of an AI-powered accounts receivable automation platform, has raised $1 million in pre-seed funding to accelerate product development and expand across France and broader European markets.